Glioblastoma Stem Cells as Targets for Emerging Precision Immunotherapies and Molecular Treatments
Cells · 26.04.2026 · 15 (9) · 783
DOI: 10.3390/cells15090783 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 26.04.2026. Verfasst von Dennis A Steindler und 1 weiteren Autor:innen. Beteiligte Einrichtung: Steindler Consulting, Boston, MA, USA. Hauptthemen laut MEDLINE: Brain Neoplasms, Glioblastoma, Immunotherapy, Molecular Targeted Therapy. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Advances in organoid and other three-dimensional culture systems, single-cell and spatial transcriptomics, multi-omics, and high-resolution imaging are reshaping our understanding of the cellular origins and evolutionary trajectories of glioblastoma. When integrated with modern data science approaches, these technologies enable the construction of increasingly detailed molecular biographies of normal neural stem and progenitor cells as well as malignant stem-like cellular states. Such molecular biographies illuminate how developmental programs, cellular plasticity, and microenvironmental cues are co-opted during gliomagenesis. At the same time, progress in machine learning, immunotherapy, and precision molecular targeting is beginning to translate these biological insights into therapeutic strategies that specifically disrupt glioblastoma stem-like states. Together, these converging approaches provide a conceptual and technological framework for improved tumor modeling, earlier detection, and increasingly personalized therapies for malignant gliomas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Steindler Consulting, Boston, MA, USA.
- Round Table Research, Inc., Research Triangle Park, Chapel Hill, NC 27709, USA.
- The Eshelman Institute for Innovation, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
- School of Pharmacy and Life Sciences, Research Institute of Healthcare Sciences, University of Wolverhampton, City Campus, Wolverhampton WV1 1LY, UK.
ORCID-Profile: Dennis A Steindler, Katherine Karakoula
Zitieren
APA
Steindler, D. A., & Karakoula, K. (2026). Glioblastoma Stem Cells as Targets for Emerging Precision Immunotherapies and Molecular Treatments. Cells, 15(9), 783. https://doi.org/10.3390/cells15090783
Vancouver
Steindler DA, Karakoula K. Glioblastoma Stem Cells as Targets for Emerging Precision Immunotherapies and Molecular Treatments. Cells. 2026;15(9):783. doi:10.3390/cells15090783
BibTeX
@article{Steindler2026,
author = {Steindler, Dennis A and Karakoula, Katherine},
title = {Glioblastoma Stem Cells as Targets for Emerging Precision Immunotherapies and Molecular Treatments},
journal = {Cells},
year = {2026},
volume = {15},
number = {9},
pages = {783},
doi = {10.3390/cells15090783}
}
EUVIMED